{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:35:13Z","timestamp":1787808913984,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.gassur.2025.102301","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T07:52:40Z","timestamp":1766130760000},"page":"102301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A single-center retrospective study of conversion surgery in stage IV gastric cancer: association with immune checkpoint inhibitor-based chemotherapy"],"prefix":"10.1016","volume":"30","author":[{"given":"Yuki","family":"Ushimaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Masuike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"Yanagimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Sugase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kitakaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisateru","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Miyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Sueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihito","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gassur.2025.102301_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.gassur.2025.102301_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","article-title":"Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial","volume":"17","author":"Fujitani","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2025.102301_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ags3.12515","article-title":"International retrospective cohort study of conversion therapy for Stage IV gastric Cancer 1 (CONVO-GC-1)","volume":"6","author":"Yoshida","year":"2022","journal-title":"Ann Gastroenterol Surg"},{"issue":"1","key":"10.1016\/j.gassur.2025.102301_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/07357907.2018.1551898","article-title":"Conversion surgery for unresectable advanced gastric cancer: a systematic review and meta-analysis","volume":"37","author":"Du","year":"2019","journal-title":"Cancer Investig"},{"issue":"1","key":"10.1016\/j.gassur.2025.102301_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1186\/s12885-017-3918-9","volume":"17","author":"Al-Batran","year":"2017","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.gassur.2025.102301_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10120-015-0575-z","article-title":"Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification","volume":"19","author":"Yoshida","year":"2016","journal-title":"Gastric Cancer"},{"issue":"17","key":"10.1016\/j.gassur.2025.102301_bib7","volume":"42","author":"Al-Batran","year":"2024","journal-title":"J Clin Oncol"},{"issue":"10111","key":"10.1016\/j.gassur.2025.102301_bib8","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","article-title":"Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"Kang","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.gassur.2025.102301_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.oraloncology.2019.06.016","article-title":"Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer","volume":"95","author":"Park","year":"2019","journal-title":"Oral Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2025.102301_bib10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1158\/2326-6066.CIR-14-0040","article-title":"In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates","volume":"2","author":"Wang","year":"2014","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"10.1016\/j.gassur.2025.102301_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2016.12.180","article-title":"Chemoimmunotherapy by combining oxaliplatin with immune checkpoint blockades reduced tumor burden in colorectal cancer animal model","volume":"487","author":"Wang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"10294","key":"10.1016\/j.gassur.2025.102301_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.gassur.2025.102301_bib13","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1470-2045(23)00515-6","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial","volume":"24","author":"Rha","year":"2023","journal-title":"Lancet Oncol"},{"issue":"10142","key":"10.1016\/j.gassur.2025.102301_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(18)31257-1","article-title":"Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial","volume":"392","author":"Shitara","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gassur.2025.102301_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","article-title":"Japanese classification of gastric carcinoma: 3rd English edition","volume":"14","author":"Japanese Gastric Cancer Association","year":"2011","journal-title":"Gastric Cancer"},{"issue":"2","key":"10.1016\/j.gassur.2025.102301_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"18","key":"10.1016\/j.gassur.2025.102301_bib17","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N Engl J Med"},{"issue":"33","key":"10.1016\/j.gassur.2025.102301_bib18","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","article-title":"Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer","volume":"29","author":"Sasako","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9813","key":"10.1016\/j.gassur.2025.102301_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","article-title":"Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (Classic): a phase 3 open-label, randomised controlled trial","volume":"379","author":"Bang","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gassur.2025.102301_bib20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s10120-016-0606-4","article-title":"Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study","volume":"20","author":"Fuse","year":"2017","journal-title":"Gastric Cancer"},{"issue":"15","key":"10.1016\/j.gassur.2025.102301_bib21","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1200\/JCO.18.01138","article-title":"Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with Stage III gastric cancer: interim analysis of JACCRO GC-07, a randomized controlled trial","volume":"37","author":"Yoshida","year":"2019","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2025.102301_bib22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.annonc.2020.11.017","article-title":"A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial\u2606","volume":"32","author":"Park","year":"2021","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2025.102301_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10120-017-0738-1","article-title":"The long-term survival of stage IV gastric cancer patients with conversion therapy","volume":"21","author":"Yamaguchi","year":"2018","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.gassur.2025.102301_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1245\/s10434-024-16440-0","article-title":"Effect of minimally invasive gastrectomy on return to intended oncologic therapy for gastric cancer","volume":"32","author":"Koo","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2025.102301_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10120-025-01601-1","article-title":"Robotic and laparoscopic gastrectomy for gastric cancer: comparative insights into perioperative performance and three-year survival outcomes","volume":"28","author":"Ushimaru","year":"2025","journal-title":"Gastric Cancer"},{"issue":"4","key":"10.1016\/j.gassur.2025.102301_bib26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ags3.12343","article-title":"Minimally invasive surgery is feasible after preoperative chemotherapy for stage IV gastric cancer","volume":"4","author":"Yamamoto","year":"2020","journal-title":"Ann Gastroenterol Surg"},{"issue":"8","key":"10.1016\/j.gassur.2025.102301_bib27","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1007\/s00464-022-09125-w","article-title":"Comparison of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer: a propensity score-matched analysis","volume":"36","author":"Omori","year":"2022","journal-title":"Surg Endosc"},{"issue":"7","key":"10.1016\/j.gassur.2025.102301_bib28","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1007\/s00268-020-05486-2","article-title":"Is laparoscopic gastrectomy more advantageous for elderly patients than for young patients with resectable advanced gastric cancer?","volume":"44","author":"Ushimaru","year":"2020","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.gassur.2025.102301_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamasurg.2021.5104","article-title":"Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: five-year outcomes from the CLASS-01 randomized clinical trial","volume":"157","author":"Huang","year":"2022","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.gassur.2025.102301_bib30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jamaoncol.2018.6727","article-title":"Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with Stage I gastric cancer: the KLASS-01 randomized clinical trial","volume":"5","author":"Kim","year":"2019","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.gassur.2025.102301_bib31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jamasurg.2022.2749","article-title":"Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: 5-year outcomes of the KLASS-02 randomized clinical trial","volume":"157","author":"Son","year":"2022","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.gassur.2025.102301_bib32","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/SLA.0000000000002768","article-title":"Long-term outcomes of laparoscopic versus open surgery for clinical stage II\/III gastric cancer: a multicenter cohort study in Japan (LOC-A study)","volume":"269","author":"Kinoshita","year":"2019","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.gassur.2025.102301_bib33","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1093\/oncolo\/oyab069","article-title":"Clinical progress in inoperable or recurrent advanced gastric cancer treatment from 1004 single institute experiences between 2007 and 2018","volume":"27","author":"Nakayama","year":"2022","journal-title":"Oncologist"},{"issue":"17","key":"10.1016\/j.gassur.2025.102301_bib34","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1200\/JCO.23.01601","article-title":"First-line nivolumab plus chemotherapy for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 3-year follow-up of the phase III CheckMate 649 trial","volume":"42","author":"Janjigian","year":"2024","journal-title":"J Clin Oncol"},{"issue":"10389","key":"10.1016\/j.gassur.2025.102301_bib35","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.gassur.2025.102301_bib36","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","article-title":"Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial","volume":"29","author":"Shah","year":"2023","journal-title":"Nat Med"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X25003609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X25003609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:31:32Z","timestamp":1768962692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X25003609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1091255X25003609"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2025.102301","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single-center retrospective study of conversion surgery in stage IV gastric cancer: association with immune checkpoint inhibitor-based chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2025.102301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102301"}}